logo
Wearable devices helped spot postsurgical complications in kids

Wearable devices helped spot postsurgical complications in kids

Wearable devices like Fitbits can help health care providers spot postsurgical complications in kids, a new analysis in Science Advances finds.
About 1 in 7 children will have postoperative complications, but diagnoses can be delayed because they can be difficult for caretakers outside the hospital to spot.
To determine if data recorded by wearable devices can help predict recovery in children, researchers gave Fitbits to 103 children ages 3 to 18. All were recovering from an appendectomy, a common surgery in kids. The devices monitored heart rate and step-count data, sleep and other biometrics. They recorded 2,163 total monitoring days.
The researchers used the data to find circadian patterns in the children's biometrics during each day after their surgery. Of 94 children whose data could be used, 58 had a normal recovery, 23 had abnormal symptoms such as diarrhea but no ultimate complication, and 13 had a postoperative complication.
The researchers used a machine-learned model to predict complications using the Fibits and biorhythms. Daily patterns associated with activity, such as step count, ended up being the most important to predicting post-appendectomy recovery, followed by heart rhythms. Tracking biorhythms for as little as 120 minutes produced robust enough data for the model to analyze.
Overall, the researchers were able to predict postoperative complications using the wearable data with 91 percent sensitivity and 74 percent specificity.
'In our data, 89% of patients who had complications after discharge were readmitted and were all correctly predicted by the biorhythm model,' they write.
Other research suggests biorhythms may not be as effective at tracking adults' postoperative recovery. It might be easier to use biometrics to predict children's recoveries because their lives are more structured, making it easier to establish a typical baseline for analysis, the researchers add.
Other studies should focus on other childhood procedures including tonsillectomies, the researchers suggest. But overall, the researchers write, the study shows that consumer wearables and monitoring could help 'address key challenges in postoperative monitoring of children.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

These Markers May Predict Risk for Bone Loss in SLE
These Markers May Predict Risk for Bone Loss in SLE

Medscape

time4 hours ago

  • Medscape

These Markers May Predict Risk for Bone Loss in SLE

TOPLINE: Osteoporosis was prevalent in 41% of patients with systemic lupus erythematosus (SLE). Factors such as lupus nephritis classes III and IV, U1-ribonucleoprotein (RNP) antibodies, and longer disease duration were associated with lower areal bone mineral density (BMD), and active lupus nephritis was associated with osteoporosis. METHODOLOGY: Researchers analysed data of a subcohort of patients from a prospective observational study to identify factors associated with BMD and the risk for osteoporosis. They included 110 patients with SLE (mean age, 48 years; 92% women) from a hospital in Berlin between July 2015 and January 2022 who fulfilled the American College of Rheumatology/ European League Against Rheumatism 2019 SLE classification criteria and had current or prior glucocorticoid treatment. The analysis included SLE disease activity and a standardised bone health assessment with the DEXA scan and trabecular bone score measurement according to national guidelines. BMD- and osteoporosis-related factors were assessed. The following three co-primary endpoints were assessed: Areal BMD, expressed as the lowest DEXA-derived T score at the lumbar spine (L1-L4), total hip, or femoral neck A composite osteoporosis outcome (a femoral or lumbar spine T score ≤ -2.5 and/or history of a major fragility fracture and/or antiosteoporotic treatment) The prevalence of fragility fractures (any, vertebral, and non-vertebral). TAKEAWAY: Overall, 41% and 35% of patients with SLE had osteoporosis and lupus nephritis, respectively. Factors significantly associated with lower areal BMD included lupus nephritis classes III and IV (P = .025), U1-RNP antibodies (P = .009), higher C-reactive protein levels (P = .015), and longer disease duration (P = .001). Clinical remission (P = .033) and higher Health Assessment Questionnaire scores (P = .009) were positively correlated with areal BMD. Active lupus nephritis was strongly associated with osteoporosis in patients with SLE (odds ratio [OR], 7.42; P = .027), along with other factors such as older age (OR, 1.06; P = .003) and lower Health Assessment Questionnaire scores (OR, 0.29; P = .005). IN PRACTICE: "The identification of SLE-specific risk factors allows us to recognize patients at particular high risk for OP [osteoporosis]. This prompts us to suggest a thorough osteoporosis check-up in patients with high CRP [C-reactive protein], LN [lupus nephritis], or U1-RNP-antibodies," the authors wrote. SOURCE: This study was led by Edgar Wiebe, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, Berlin, Germany. It was published online on July 28, 2025, in Arthritis Research & Therapy. LIMITATIONS: This monocentric cohort study primarily involved White Caucasians, thereby limiting the generalisability of the findings to other patient groups. A potential selection bias may have resulted in overrepresentation of patients with more severe disease courses who were at a high risk for osteoporosis. The cross-sectional design limited the ability to establish causality between identified factors and outcomes. DISCLOSURES: Open access funding was enabled and organised by Projekt DEAL. The prospective observational study received a joint funding from AbbVie, Amgen, Alfasigma, Almirall, Biogen, BMS, Chugai, Fresenius Kabi, Galapagos, GA Generic Assays, GSK, Hexal, Horizon Therapeutics, Lilly, Medac, Mundipharma, Novartis, Pfizer, Roche, Sanofi-Genzyme, and UCB. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Non-Invasive Test May Transform Infant Meningitis Screening
Non-Invasive Test May Transform Infant Meningitis Screening

Medscape

time4 hours ago

  • Medscape

Non-Invasive Test May Transform Infant Meningitis Screening

TOPLINE: A high-resolution ultrasound-based device demonstrated excellent accuracy in detecting elevated white blood cell (WBC) counts in cerebrospinal fluids, showing promise as a non-invasive screening tool for meningitis in neonates and infants with a permeable fontanel and potentially offering an alternative to lumbar puncture. METHODOLOGY: The diagnosis of meningitis requires an invasive lumbar puncture to collect cerebrospinal fluid for detecting elevated WBC counts; however, this procedure carries inherent risks and practical limitations. Researchers conducted a prospective study across hospitals in Spain, Mozambique, and Morocco to validate the safety and accuracy of Neosonics — a non-invasive high-resolution ultrasound-based device that can detect signals from WBCs in the cerebrospinal fluid via the anterior fontanel — in neonates and infants younger than 24 months with suspected meningitis against the gold-standard techniques. High-resolution images of the cerebrospinal fluid were captured and used to train a deep learning model that identified and classified cerebrospinal fluid patterns on the basis of lumbar puncture-confirmed WBC counts, with ≥ 30 cells/mm 3 defined as a case. defined as a case. The accuracy of the trained algorithm was tested on 3782 high-resolution images of 76 patients. TAKEAWAY: The Neosonics device correctly identified 17 of 18 meningitis cases and 55 of 58 controls participants without meningitis, yielding a sensitivity of 94.4% and a specificity of 94.8%. Overall, the device achieved an accuracy of 94.7% in detecting elevated WBC counts in the cerebrospinal fluid. Misclassified participants either had low WBC counts or were microbiologically confirmed cases without elevated WBC counts. IN PRACTICE: "The non-invasive WBC counter, can lead to a more accurate indication for LP [lumbar puncture] and/or indications of treatment, resulting in better patient outcomes and in a reduction of the risk of long-term sequelae, along with a likely more cost-effective use of resources in all settings," the authors wrote. SOURCE: This study was led by Sara Ajanovic and Quique Bassat, ISGlobal, Barcelona, Spain, and Fernando Cabañas, Quirónsalud Madrid University Hospital, Madrid, Spain. It was published online on July 23, 2025, in Pediatric Research. LIMITATIONS: This study faced challenges in obtaining reliable gold-standard comparison results. The device's precision decreased in participants with thicker fontanels, and it misclassified three participants with very narrow cerebrospinal fluid spaces. Moreover, the image acquisition time was suboptimal. DISCLOSURES: This study was supported, in whole or in part, by the Gates Foundation in Mozambique and Morocco; funded by Instituto de Salud Carlos III and co-funded by the European Union in Spain; and funded by the Spanish Agency of Cooperation in Morocco. Five authors were employees of Kriba, the company developing Neosonics. One author and the ISGlobal Biomedical Data Science team disclosed receiving honoraria, training fees, and consulting fees from Kriba. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Plastic causing "disease and death from infancy to old age," report warns
Plastic causing "disease and death from infancy to old age," report warns

Yahoo

time5 hours ago

  • Yahoo

Plastic causing "disease and death from infancy to old age," report warns

Plastic pollution is a "grave, growing and under-recognized danger" to health that is costing the world at least $1.5 trillion a year, a report published Monday in the Lancet medical journal said. The new review of existing evidence, which was carried out by leading health researchers and doctors, was published one day ahead of fresh talks in Geneva aiming at getting the world's first treaty on plastic pollution. The experts called for the delegates from nearly 180 nations expected to attend the gathering to finally agree on a treaty after previous failed attempts. Comparing plastic to air and lead pollution, the report said the impact on health of plastic pollution could be mitigated by laws and policies. "Plastics cause disease and death from infancy to old age and are responsible for health-related economic losses exceeding $1.5 trillion annually," it said. A recent umbrella review of epidemiological research on the health impacts of plastic chemicals showed "consistent evidence for multiple health effects at all stages of human life for many plastic chemicals" and found that infants and young children were especially at risk, the report said. "These effects include impaired reproductive potential (eg, polycystic ovary syndrome and endometriosis), perinatal effects (eg, miscarriage, reduced birthweight, and malformations of the genital organs), diminished cognitive function (eg, intelligence quotient loss), insulin resistance, hypertension and obesity in children, and type 2 diabetes, cardiovascular disease, stroke, obesity, and cancer in adults." "It is incumbent on us to act in response," Philip Landrigan, a doctor and researcher at Boston College, said in a statement responding to the report. "To those meeting in Geneva: please take up the challenge and the opportunity of finding the common ground that will enable meaningful and effective international cooperation in response to this global crisis." The researchers also warned about tiny pieces of plastic called microplastics that have been found throughout nature - and throughout human bodies. The full effect of microplastics on health are not yet fully known, but researchers have sounded the alarm about the potential impact of this ubiquitous plastic. The amount of plastic produced by the world has risen from two million tons in 1950 to 475 million tons in 2022, the report said. The number is projected to triple by 2060, yet currently less than 10 percent of all plastic is recycled, it added. Plastic is made from fossil fuels, and Landrigan said that the world's plastic "crisis" is connected to its climate crisis. "There is no understating the magnitude of both the climate crisis and the plastic crisis," Landrigan said. "They are both causing disease, death and disability today in tens of thousands of people, and these harms will become more severe in the years ahead as the planet continues to warm and plastic production continues to increase," he said. Black swimmers teach others amid history of aquatic segregation How safe is our Social Security safety net? In Gaza, hunger forces impossible choices as Hamas releases propaganda video of hostage

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store